Consuming regular orange juice during drug therapy
Does consumption of regular orange juice cause drug interactions, or should all citrus fruits be avoided?
Diagnosis & Disease Information
Splitting or crushing oral cancer medications
Which medicines can be split or crushed for administration?
Questions about side effects? Your patients’ perhaps not so surprising source for answers
Many cancer patients go to the Internet with their questions about side effect management. But the information they glean is from reliable sources—other cancer patients.
Fear of lymphedema after sentinel lymph node biopsy greater than risk
Despite the low risk of lymphedema after sentinel lymph node biopsy, most women worry about this complication and practice risk-reducing behaviors to avoid it.
Patient navigator: A role for nurses that goes beyond clinical care
Cancer care entails a confusing labyrinth of screenings, tests, and treatments. This emerging role for nurses is becoming increasingly vital to achieve ideal patient outcomes.
25-year survival after prostate radiation matches prostatectomy
Late recurrence of prostate cancer is rare if PSA is less than 0.2 ng/mL, the surgical PSA definition of cancer control, 15 years after treatment with radiation therapy.
Educating nurses about educating patients: Mind your words
“That’s not what I said.” Nurses need to be attentive to the signs of how a patient understands what they are told.
FDA Update: Kadcyla approved and more drug news
This column reviews the latest FDA drug news, including approvals for Kadcyla, Stivarga, Pomalidomide, and Lymphoseek.
Radiotherapy side effects: Understanding pelvic radiation disease
The key to managing this late effect is patient education because it can manifest long after patients complete radiotherapy.
Non-small cell lung cancer: Molecular targets and emerging options for care
This activity from myCME offers a review of groundbreaking molecular research and novel treatment options for patients with NSCLC.
- Loading...
Loading...
Next post in CE Courses
Loading... 
Loading...